The FDA announced on 2013-09-23 that West-Ward Pharmaceutical Corp. is recalling Irinotecan Hydrochloride Injection due to a superpotent drug hazard caused by an incorrect formulation calculation. The recall affects 9,813 vials distributed nationwide.
How to tell if you have it
- Brand: West-Ward Pharmaceutical
- Product: Irinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial per carton
- NDC: 0143-9701-01
- Lot codes: AC0026, AC0027
- Expiration date: 10/14
The hazard
A recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation, which will result in an assay higher than the labeled claim. The classification is Class II.
Context
GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since 2012-04-13. Other recent recalls of similar products include ICU Medical Recalls Potassium Chloride Injection Due to Label Error (2025-10-29), American Regent Levocarnitine Injection Recall: Missing Label Hazard (2026-04-16), and Somerset Therapeutics Cisatracurium Besylate Injection Recall: Subpotent Product Risk (2025-11-26).